aid: aegle-therapeutics
name: Aegle Therapeutics
description: 'Aegle Therapeutics Corporation is a privately held, clinical-stage regenerative
  medicine company developing extracellular vesicle (EV) therapy — a cell-free therapeutic
  composite of EVs, including exosomes, isolated from allogeneic bone marrow-derived
  mesenchymal stem cells using its proprietary EV harvesting technology. Its lead candidate,
  AGLE-102, is in a Phase 1/2 clinical study for Recessive Dystrophic Epidermolysis Bullosa
  (RDEB) and other severe dermatological disorders with significant unmet medical need.
  The company publishes a seven-page WordPress marketing site and no developer program,
  API, SDK or machine-readable specification of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/aegle-therapeutics/refs/heads/main/apis.yml
image: https://cdn.aegletherapeutics.com/app/uploads/2023/01/cropped-aegle-icon-1-270x270.png
x-type: company
x-source: harvest:secondary-market
x-harvest-source: https://www.nasdaqprivatemarket.com/
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-09'
modified: '2026-09-09'
tags:
- Company
- Biotechnology
- Life Sciences
- Regenerative Medicine
- Clinical Stage
- Pharmaceuticals
- Rare Disease
- Health
position: Producing
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://aegletherapeutics.com/
- type: About
  url: https://aegletherapeutics.com/company/
- type: Contact
  url: https://aegletherapeutics.com/contact/
- type: Newsroom
  url: https://aegletherapeutics.com/news/
- type: PrivacyPolicy
  url: https://aegletherapeutics.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/aegletherapeutics
- type: DomainSecurity
  url: security/aegle-therapeutics-domain-security.yml
- type: ContentSignal
  url: well-known/aegle-therapeutics-robots.txt
- type: LLMsTxt
  url: llms/aegle-therapeutics-llms.txt

x-enrichment:
  date: '2026-09-09'
  status: minimal
  artifacts_added: 4
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Aegle Therapeutics is a clinical-stage extracellular-vesicle drug developer whose entire
    public surface is a seven-page WordPress marketing site (home, company, EV therapy,
    pipeline, news, contact, policies) — its sitemap lists no developer, API, docs or
    pricing page, and the only machine-readable endpoint on the domain is the site's own
    /wp-json/ CMS route, which returns 401 rest_authentication_error to anonymous callers.
  evidence:
  - url: https://aegletherapeutics.com/page-sitemap.xml
    status: 200
  - url: https://aegletherapeutics.com/openapi.json
    status: 404
  - url: https://aegletherapeutics.com/llms.txt
    status: 404
  - url: https://aegletherapeutics.com/.well-known/agent-card.json
    status: 404
  - url: https://aegletherapeutics.com/wp-json/
    status: 401
  checked: '2026-09-09'